Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Zhang T, Qu R, Chan S, Lai M, Tong L, Feng F, Chen H, Song T, Song P, Bai G, Liu Y, Wang Y, Li Y, Su Y, Shen Y, Sun Y, Chen Y, Geng M, Ding K, Ding J, Xie H.
Zhang T, et al. Among authors: wang y.
Mol Cancer. 2023 Aug 19;22(1):139. doi: 10.1186/s12943-023-01842-7.
Mol Cancer. 2023.
PMID: 37598189
Free PMC article.
No abstract available.